Pancreatic Cancer
Initial clinical data from GVAX pancreatic cancer vaccine program
Published in Vaccine Weekly, July 28th, 2004
The company also updated the status of a parallel phase II trial in patients with operable pancreatic cancer who receive the vaccine after surgery, an approach which continues to be the focus of the company's GVAX pancreatic cancer vaccine program. These 2 trials were prompted by encouraging results from an earlier phase I clinical trial in operable patients which demonstrated prolonged, disease-free survival of at least 6 years in 3 of 8 patients treated at therapeutic dose...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2004-07-28)
More Articles from Vaccine Weekly
- Cancer Vaccine
Potent vaccine-induced anti-tumor T cell response characterized - DNA Vaccine
Heat-shock protein as dendritic cell target enhances vaccine potency - DNA Vaccine
Important factors for improving efficacy of DNA vaccines described - Human Papillomavirus Vaccine
Presentation system improves cellular immunity against papillomavirus - Virology Vaccine
Dendritic cell vaccine induces antiviral immunity - Adolescent Health
Adolescents and immunization: Tips for the primary care provider - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
